Warm congratulations on Weixinkang Medicine Co., Ltd. for winning the title of "Top 10 Most Valuable Listed Pharmaceutical Companies 2017".-Company news-Enterprise information-Tibet WeiXinKang Medicine CO., LTD.

-Enterprise information-

Warm congratulations on Weixinkang Medicine Co., Ltd. for winning the title of "Top 10 Most Valuable Listed Pharmaceutical Companies 2017".

Date:2017-11-20 browse: Author: WeiXinkang
Share:

  After more than a month's preparation and selection, involving hundreds of thousands of industry professionals, the "New Prominent List of Chinese Medicine 2017" launched by the www.yygcj.com is formally closed on November 10. Weixinkang Medicine Co., Ltd. topped on the New Prominent List of Chinese Medicine and won the award of "Top 10 Most Valuable Pharmaceutical Listed Companies 2017". 





  

    The public welfare brand activity of "New Prominent List of Chinese Medicine 2017" launched by the www.yygcj.com and sponsored by China Medical Pharmaceutical Material Association, China Pharmaceutical Enterprise Association and China Association of Health Industry and Enterprise Management, focused on multiple dimensions from "The Most Valuable Pharmaceutical Listed Companies", "The Most Commercial Innovative Pharmaceutical Companies" and "The Most Competitive New Prominent Products". This is a credible selection and has been highly praised in the industry.

    Weixinkang Medicine Co., Ltd. has been committed to becoming a professional imitation and innovation pharmaceutical company respected by Chinese society and the public. It always adheres to the clinical needs as the guide, continues the innovation and seeks truth. At present, the core products of the company have covered many professional fields such as parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, and medicine for digestive system and liver diseases. In the future, Weixinkang Medicine Co., Ltd. will continue the innovation to create more advantageous varieties with definite clinical efficacy and broad market prospects and make greater contribution to the medical and health work in China!